Phase 3 Study PACIFICA: A Randomized, Controlled Phase 3 Study of Pacritinib versus Physician?s Choice in Patients with Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia Platelet Counts

Brief Summary

Type:
Myelofibrosis

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03165734

Study #:
STUDY00141532

Start Date:
Dec 11, 2017

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03165734

View Complete Trial Details & Eligibility at ClinicalTrials.gov